Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 13, 2014 - Issue sup1: The contribution of active Pharmacovigilance projects to the Italian National Spontaneous Reporting System
Submit an article Journal homepage
324
Views
15
CrossRef citations to date
0
Altmetric
Case Series

Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation

Annalisa CapuanoSecond University of Naples, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Faculty of Medicine and Surgery, Via De Crecchio, 7, 80138 Naples, Italy+39 0815667669; +39 0815667652; [email protected]
,
Cristina ScavoneSecond University of Naples, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Faculty of Medicine and Surgery, Via De Crecchio, 7, 80138 Naples, Italy+39 0815667669; +39 0815667652; [email protected]
,
Concetta RafanielloSecond University of Naples, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Faculty of Medicine and Surgery, Via De Crecchio, 7, 80138 Naples, Italy+39 0815667669; +39 0815667652; [email protected]
,
Romano ArcieriIstituto Superiore di Sanità (Italian National Institute of Health), Department of Pharmacology and Therapeutic Research, Child Health Unit, Viale Regina Elena, 299 – 00161, Roma, Italy
,
Francesco RossiSecond University of Naples, Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Faculty of Medicine and Surgery, Via De Crecchio, 7, 80138 Naples, Italy+39 0815667669; +39 0815667652; [email protected]
&
Pietro PaneiIstituto Superiore di Sanità (Italian National Institute of Health), Department of Pharmacology and Therapeutic Research, Child Health Unit, Viale Regina Elena, 299 – 00161, Roma, Italy
Pages 69-78 | Published online: 29 Aug 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Erika Ryst & Ann Childress. (2023) An updated safety review of the current drugs for managing ADHD in children. Expert Opinion on Drug Safety 22:11, pages 1025-1040.
Read now
Antonio Clavenna & Maurizio Bonati. (2017) Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD. Expert Opinion on Drug Safety 16:12, pages 1335-1345.
Read now
Keith Fluegge. (2016) Atomoxetine, ADHD, and the ongoing debate about increased risk of suicidal behaviors: the understudied role of kappa opioid receptor agonism. Expert Opinion on Drug Safety 15:8, pages 1147-1147.
Read now

Articles from other publishers (12)

Wei Wei, Li Chen, Hui Zhou, Jinfeng Liu, Yue Zhang, Shiyu Feng, Yingtao Bai, Yanen Leng, En Chang & Liang Huang. (2023) Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system. Frontiers in Pharmacology 14.
Crossref
Jae Heon Kim, Suyeon Park & Yeon Jung Lee. (2023) Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 34:2, pages 125-132.
Crossref
Cristina Scavone, Barbara Stelitano, Concetta Rafaniello, Francesco Rossi, Liberata Sportiello & Annalisa Capuano. (2019) Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System. Journal of Gambling Studies 36:1, pages 85-96.
Crossref
Gianluca Trifirò, Rosa Gini, Francesco Barone-Adesi, Ettore Beghi, Anna Cantarutti, Annalisa Capuano, Carla Carnovale, Antonio Clavenna, Mirosa Dellagiovanna, Carmen Ferrajolo, Matteo Franchi, Ylenia Ingrasciotta, Ursula Kirchmayer, Francesco Lapi, Roberto Leone, Olivia Leoni, Ersilia Lucenteforte, Ugo Moretti, Alessandro Mugelli, Luigi Naldi, Elisabetta Poluzzi, Concita Rafaniello, Federico Rea, Janet Sultana, Mauro Tettamanti, Giuseppe Traversa, Alfredo Vannacci, Lorenzo Mantovani & Giovanni Corrao. (2018) The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. Drug Safety 42:3, pages 347-363.
Crossref
Cristina Scavone, Gabriella di Mauro, Annamaria Mascolo, Liberato Berrino, Francesco Rossi & Annalisa Capuano. (2019) The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. Frontiers in Pharmacology 10.
Crossref
Carla Carnovale, Faizan Mahzar, Sara Scibelli, Marta Gentili, Elena Arzenton, Ugo Moretti, Olivia Leoni, Marco Pozzi, Gabriëlla G.A.M. Peeters, Emilio Clementi, Massimo Medaglia & Sonia Radice. (2018) Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance database. European Journal of Pediatrics 178:2, pages 161-172.
Crossref
Lenard A. Adler & Stephen W. Gorny. (2015) Pilot Study of Droxidopa With Carbidopa in Adults With ADHD. Journal of Attention Disorders 23:2, pages 189-198.
Crossref
Cristina Scavone, Maurizio Sessa, Emilio Clementi, Giovanni Corrao, Roberto Leone, Alessandro Mugelli, Francesco Rossi, Edoardo Spina & Annalisa Capuano. (2018) Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study. BioDrugs 32:6, pages 607-617.
Crossref
Judit Balazs & Agnes Kereszteny. (2017) Attention-deficit/hyperactivity disorder and suicide: A systematic review. World Journal of Psychiatry 7:1, pages 44.
Crossref
M. Davies, A. Coughtrie, D. Layton & S.A.S. Shakir. (2020) Use of atomoxetine and suicidal ideation in children and adolescents: Results of an observational cohort study within general practice in England. European Psychiatry 39, pages 11-16.
Crossref
Antonio Clavenna & Maurizio Bonati. 2016. Pharmacovigilance in Psychiatry. Pharmacovigilance in Psychiatry 233 253 .
. (2014) Atomoxetine/haloperidol/niaprazine/sodium valproate. Reactions Weekly 1522:1, pages 41-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.